The emergence of clinical isolates capable of manufacturing extended spectrum beta lactamase (ESBL) has posed treatment problems. As a result, ESBLs are becoming a growing clinical problem around the world because they transmit resistance to broad range -lactam antibiotics. Because neonates are more susceptible to infections, infections are a...